Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling study.

Marc d'Elbée ; Martin Harker ORCID logo ; Nyashadzaishe Mafirakureva ; Mastula Nanfuka ; Minh Huyen Ton Nu Nguyet ; Jean-Voisin Taguebue ; Raoul Moh ; Celso Khosa ; Ayeshatu Mustapha ; Juliet Mwanga-Amumpere ; +16 more... Laurence Borand ; Sylvie Kwedi Nolna ; Eric Komena ; Saniata Cumbe ; Jacob Mugisha ; Naome Natukunda ; Tan Eang Mao ; Jérôme Wittwer ; Antoine Bénard ; Tanguy Bernard ; Hojoon Sohn ; Maryline Bonnet ; Eric Wobudeya ; Olivier Marcy ; Peter J Dodd ; TB-Speed Health Economics Study Group ; (2024) Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling study. EClinicalMedicine, 70. 102528-. ISSN 2589-5370 DOI: 10.1016/j.eclinm.2024.102528
Copy

BACKGROUND: The burden of childhood tuberculosis remains high globally, largely due to under-diagnosis. Decentralising childhood tuberculosis diagnosis services to lower health system levels could improve case detection, but there is little empirically based evidence on cost-effectiveness or budget impact. METHODS: In this mathematical modelling study, we assessed the cost-effectiveness and budget impact of decentralising a comprehensive diagnosis package for childhood tuberculosis to district hospitals (DH-focused) or primary health centres (PHC-focused) compared to standard of care (SOC). The project was conducted in Cambodia, Cameroon, Côte d'Ivoire, Mozambique, Sierra Leone, and Uganda between August 1st, 2018 and September 30th, 2021. A mathematical model was developed to assess the health and economic outcomes of the intervention from a health system perspective. Estimated outcomes were tuberculosis cases, deaths, disability-adjusted life years (DALYs) and incremental cost-effectiveness ratios (ICERs). We also calculated the budget impact of nationwide implementation. The TB-Speed Decentralization study is registered with ClinicalTrials.gov, NCT04038632. FINDINGS: For the DH-focused strategy versus SOC, ICERs ranged between $263 (Cambodia) and $342 (Côte d'Ivoire) per DALY averted. For the PHC-focused strategy versus SOC, ICERs ranged between $477 (Cambodia) and $599 (Côte d'Ivoire) per DALY averted. Results were sensitive to TB prevalence and the discount rate used. The additional costs of implementing the DH-focused strategy ranged between $12.8 M (range 10.8-16.4) (Cambodia) and $50.4 M (36.5-74.4) (Mozambique), and between $13.9 M (12.6-15.6) (Sierra Leone) and $134.6 M (127.1-143.0) (Uganda) for the PHC-focused strategy. INTERPRETATION: The DH-focused strategy may be cost-effective in some countries, depending on the cost-effectiveness threshold used for policy making. Either intervention would require substantial early investment. FUNDING: Unitaid.

picture_as_pdf

picture_as_pdf
Elbee-etal-2024-Cost-effectiveness-and-budget-impact-of-decentralising-childhood-tuberculosis-diagnosis.pdf
subject
Published Version
Available under Creative Commons: Attribution 4.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads